All news
Policy News – Looking Ahead to 2022!
26 November 2021DiCE policy activities into 2022 – an update
...Biosimilars Education Microsite Updates
26 November 2021Discover our new website section dedicated to Biosimilars Education – medication that can increase accessibility for patients
...2021 Masterclass Series – Materials Available and Thank you
26 November 2021Our 2021 Masterclass has come to an end – find here a summary of all sessions and links to materials
...Spanish Member ACCGG Moves Forward for Gastric Cancer Awareness Month
25 November 2021Spanish Member ACCGG Moves Forward for Gatsric Cancer Awareness Month
...We Have a Winner! Results of the Wolfram Nolte Memorial Award
25 November 2021We are pleased to announce the 2021 Winner of the Wolfram Nolte Memorial Award – EuropaColon Polska!
...The EC Approves Nivolumab Plus Chemotherapy as First Line Treatment for Oesophageal Cancer
25 November 2021European Commission approves nivolumab plus chemotherapy as first line treatment for oesophageal cancer
...15-year Anniversary of Biosimilars in Europe – What Does This mean for Patients?
29 October 2021DiCE publishes biosimilars education materials for patients and health care professionals for Global Biosimilars Week
...New Nutrition App Available to Help Cancer Patients on a Daily Basis
29 October 2021New nutrition app ‘Zest’ looking to ease the nutritional burden for cancer patients
...Organisational Announcement – Many Thanks to Vítor Neves!
27 October 2021Organisational announcement – DiCE Board Member steps down
...Raising Awareness of Pancreatic Cancer on November 18
27 October 2021Join us on November 18 to raise awareness of pancreatic cancer on World Pancreatic Cancer Day
...